1-Endovascular Treatment of the “Failing to Mature” Arteriovenous Fistula
GM Nassar, B Nguyen, E Rhee, K Achkar
Clinical Journal of the American Society of Nephrology 1 (2), 275-280: 2006.
2-Bortezomib in Kidney Transplantation
R Raghavan, A Jeroudi, K Achkar, AO Gaber, SJ Patel, A Abdellatif
Journal of transplantation 2010.
3-Pulmonary Alveolar Proteinosis in a Kidney Tansplant: A Rare Complication of Sirolimus
H Kadikoy, M Paolini, K Achkar, W Suki, AO Gaber, N Anwar, A Jeroudi
Nephrology Dialysis Transplantation 25 (8), 2795-2798 : 2010.
4-Bortezomib in Kidney Transplant Desensitization: A Case Report.
R Raghavan, A Jeroudi, K Achkar, W Suki, AO Gaber, R Knight, G Land
Clinical transplants, 339-342: 2008.
5-ASDIN Original Investigations: Salvage of a Severely Dysfunctional Arteriovenous Fistula with a Strictured and Occluded Outflow Tract
K Achkar, GM Nassar
Seminars in dialysis 18 (4), 336-342: 2005.
6- Contrast-Induced Nephropathy
NMA Mohammed, A Mahfouz, K Achkar, IM Rafie, R Hajar
Heart views: the official journal of the Gulf Heart Association 14 (3), 106: 2013.
7-The Role of mTOR Inhibition in Renal Transplant Immune Suppression
SJ Patel, KL Dawson, RJ Knight, A Abdellatif, K Achkar, LW Gaber
Dialysis & Transplantation 40 (1), 23-29: 2011.
8-Simultaneous Kidney-Pancreas Transplantation for Esrd Patients With Insulin-Dependent Diabetes and Detectable C-Peptide
RJ Knight, A Lawless, SJ Patel, K Achkar, A Abdellatif, AO Gaber
Transplantation 90, 982: 2010.
9-Occurrance of Donor Specific Antibody (DSA) Within the First Year Post-Renal Transplantation
RJ Knight, G Land, S Dilioglou, S Patel, K Achkar, A Abdellatif, L Gaber
AMERICAN JOURNAL OF TRANSPLANTATION 10, 415-415 : 2010.
10-Percutaneous Thrombectomy of AVF: Immediate Success and Long‐term Patency Rates
GM Nassar, E Rhee, AJ Khan, B Nguyen, K Achkar, G Beathard
Seminars in Dialysis 2014.
11-Outcomes of Arteriovenous Grafts Following Simultaneous Thrombectomy and Stent Graft Placement Across the Venous Anastomosis
GM Nassar, D Suki, E Rhee, AJ Khan, B Nguyen, K Achkar
Seminars in dialysis 27 (6), 639-644: 2014.
12-Characteristics of Patients Who Develop Donor Specific Antibodies through Routine Monitoring.
JM DeVos, SJ Patel, RJ Knight, AO Gaber, K Achkar, KL Dawson
AMERICAN JOURNAL OF TRANSPLANTATION 11, 192-192: 2011.
13-Significance of De Novo Donor Specific DQ Antibodies after Kidney Transplantation
JM DeVos, SJ Patel, G Land, KA Achkar, RJ Knight, KL Dawson
AMERICAN JOURNAL OF TRANSPLANTATION 11, 294-294: 2011.
14-Outcomes in Kidney Transplant Recipients That Develop De Novo Donor Specific Antibodies
JM DeVos, SJ Patel, G Land, RJ Knight, K Achkar, S Dilioglou
AMERICAN JOURNAL OF TRANSPLANTATION 11, 294-294: 2011.
15-Donor Specific Antibodies and CMV Infection in Kidney/Kidney-Pancreas Recipients.
SJ Patel, JM Devos, RJ Knight, G Land, K Achkar, SJ Dilioglou, AO Gaber
AMERICAN JOURNAL OF TRANSPLANTATION 11, 43-43: 2011.
16- Evaluation of AVG Outcomes Following Thrombectomy with Placement of Covered Stents at the Venous Anastomosis
PD George Nassar, M.D., Katafan Achkar, M.D.
ASDIN 7th Annual Scientific Meeting 2011.
17-A Graded Desensitization Treatment Protocol for Management of Living Donor Recipients With Donor Specific Antibody
RJ Knight, SJ Patel, K Achkar, G Land, S Dilioglou, J Hamilton, P Barretto
Transplantation 90, 85: 2010.
18-Influence of Pulsatile Perfusion in High Risk Kidney Transplant Patients Receiving Thymoglobulin Induction
SJ Patel, KL Dawson, RJ Knight, K Achkar, A Abdellatif, AO Gaber
Transplantation 90, 951: 2010.
19-Infectious Complications Following Rituximab Therapy in Renal Transplantation.
SJ Patel, JM Devos, AT Tong, KL Dawson, RJ Knight, K Achkar
AMERICAN JOURNAL OF TRANSPLANTATION 10, 97-97: 2010.
20-Renal Transplant Outcomes Utilizing a Prospective Screening Protocol for BK Viremia
RJ Knight, SJ Patel, K Achkar, A Abdellatif, L Gaber, L Truong, AO Gaber
AMERICAN JOURNAL OF TRANSPLANTATION 10, 448-448: 2010.
21-Endovascular Treatment of Immature Arterivenous Fistulae (AVF) Results in High Salvage Rates with Minimal Complications
Nassar, G., Nguyen, B., and Achkar, K.
American Society of Diagnostic and Interventional Nephrology (ASDIN), 2005.
22-Endovascular Treatment of Immature Arterivenous Fistulae (AVF) Results in High Salvage Rates with Minimal Complications
J Nassar, G.M., Achkar, K., Suki, W.N., Brennan, S
American Society of Nephrology 37th Annual Meeting, St. Louis, Missouri. 2004.
23-Nursing judgement, Vascular Access History, and Vascular access Flow Rate Are Important Predictive Factors of Impending Arteriovenous Access Thrombosis.
GM Nassar, K Achkar, S Brennan, WN Suki, JM Gonzalez, AJ Khan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14, 724A-724A:2003.
24-Improvement of Hemodialysis Vascular Access Blood Flow Rate with Angioplasty: Results From a Vascular Access Surveillance Program Using Transonics.
GM Nassar, K Achkar, WN Suki, S Brennan, JM Gonzalez, AJ Khan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 14, 723A-723A: 2003.
25-Measurement of Intradialytic Dynamic Venous Pressures Does Not Predict Hemodialysis Arteriovenous Access Thrombotic Events
GM Nassar, JM Gonzalez, S Brennan, K Achkar, AJ Khan, E Rhee
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 13, 235A-235A: 2002.
26-Low dialysate [K+](Kd) Decreases Efficiency of Hemodialysis (HD) and Increases Urea Rebound.
GM Dolson, K Achkar, HJ Adrogue
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 8, A0741-A0741: 1997.